“If left unaddressed, [non-communicable diseases (NCDs)] will lead to more death, disability and the implosion of already overburdened health systems in developing countries at huge cost to individuals, families, businesses and society,” Peter Piot, director of the London School of Hygiene and Tropical Medicine and former UNAIDS executive director, writes in the Huffington Post “Impact” blog, adding, “Like AIDS, NCDs are a problem for rich and poor countries alike, but the poor suffer the most.” He continues, “The 2011 U.N. High-Level Meeting on NCDs — only the second time the U.N. had convened a major meeting on a health issue, following the U.N. AIDS Summit in June 2001 — was a landmark event in the short history of the fight against NCDs but was not a tipping point. Much more remains to be done.”
Non Communicable Disease/Chronic Disease
“Cancers, cardiovascular diseases, chronic lung diseases and diabetes — four of the biggest killers among the group together known as non-communicable diseases (NCDs) — have emerged as one of the greatest social and economic development challenges of this century,” George Alleyne, director emeritus of PAHO, and Nils Daulaire, director of the Office of Global Affairs at the Department of Health & Human Services and the U.S. representative on the WHO’s Executive Board, write in the Huffington Post’s “Impact” blog. “On the first anniversary of the United Nations High-Level Meeting on NCDs where the world formally acknowledged the urgent need for action on these under-recognized diseases, it makes sense to assess how far we’ve come, as well as how much further we need to go,” they continue, adding, “During the past 12 months, health workers, policymakers and activists rallied around the High-Level Meeting to build a robust civil society movement, which has continued to gather momentum.”
“A new way to screen poor women for cervical cancer was introduced this month in El Salvador, using a test that was originally developed in China,” the New York Times reports. “The new test, called careHPV and made by Qiagen, a Dutch company, is a swab test for the DNA of the papillomaviruses that cause cancer,” the newspaper writes, noting a study published in the Lancet Oncology in 2008 found the test “was more than twice as sensitive” than the alternate method of “shining a light on the cervix and painting it with vinegar, which reveals precancerous lesions that can then be burned off with liquid nitrogen or carbon dioxide.” According to the New York Times, “The test worked even when women inserted the swabs themselves, which can be done at home and so is easier and faster than having them go to a clinic for visual inspections” (McNeil, 9/24).
“Two fifths of men in developing countries still smoke or use tobacco, and women are increasingly starting to smoke at younger ages, according to a large international study which found ‘alarming patterns’ of tobacco use,” Reuters reports (Kelland, 8/17). The study, published Friday in the Lancet, “covered enough representative samples to estimate tobacco use among three billion people” and “‘demonstrates an urgent need for policy change in low- and middle-income countries,’ said lead researcher Gary Giovino,” according to CNN (Levs, 8/17). “‘Although 1.1 billion people have been covered by the adoption of the most effective tobacco control policies since 2008, 83 percent of the world’s population are not covered by two or more of these policies,’ said [Giovino],” Reuters adds (8/17).
“As the world’s cities become home to a greater percentage of the population, better urban planning will be needed to reduce … negative health impacts [such as air pollution and obesity], according to a new report from the University College London/Lancet Commission on Healthy Cities,” the Atlantic Cities reports (Berg, 5/30). With…
Target Of 25% Reduction In Premature Mortality From NCDs By 2025 A 'Rallying Call' For Global Health Community
Member states at the 65th session of the World Health Assembly, which concluded last week, “agreed to adopt a global target of a 25 percent reduction in premature mortality from non-communicable diseases [NCDs] such as cardiovascular disease, cancer, diabetes and chronic respiratory diseases by 2025,” Devi Sridhar, a lecturer in Global Health Politics at Oxford University; Lawrence Gostin, professor of law at Georgetown University, faculty director of the O’Neill Institute for National and Global Health Law, and director of the WHO’s Collaborating Center on Public Health Law and Human Rights; and Derek Yach, senior vice president of global health and agricultural policy at PepsiCo and former executive of the WHO, write in the journal Global Health Governance. The authors discuss the basis on which the target was set and examine what will need to be done, and by whom, in order to achieve the goal.
The WHO on Wednesday released its World Health Statistics 2012 report, which “for the first time includes a look at blood pressure and glucose levels, two of the risk factors for diabetes and cardiovascular disease,” according to the Associated Press/Washington Post (5/16). The “data showed one in three adults worldwide has raised blood pressure — the cause of around half of all deaths from stroke and heart disease — and the condition affects almost half the adult population in some countries in Africa,” Reuters writes (Kelland, 5/16). “One in 10 people are estimated to have diabetes, rising to up to one third in Pacific Island countries,” Agence France-Presse notes (5/16). According to Reuters, “Obesity is another major issue, the WHO said, with data showing rates of obesity doubling in every region of the world between 1980 and 2008” (5/16). “This report is further evidence of the dramatic increase in the conditions that trigger heart disease and other chronic illnesses, particularly in low- and middle-income countries,” WHO Director-General Margaret Chan said, the news agency reports (5/16).
In this BMJ Groups Blog post, Amanda Glassman, director of Global Health Policy at the Center for Global Development, writes about the challenges the WHO faces in “[s]etting priorities and fully funding those priorities.” She defines the criteria by which the WHO could outline its priorities, including by identifying “global” and “shared” concerns and adequately funding and staffing priority areas. Glassman concludes, “There is tentative movement towards limiting the number of new resolutions based on ‘an assessment of their strategic value, financial and administrative implications, and reporting requirements and timelines.’ That sounds very good, and would inspire more confidence if the assessment were rigorous and transparent to member states and the public. Still, the reform seems to have punted on the WHO’s priority-setting problem” (5/17).
“Opening the 65th annual World Health Assembly (WHA) [on Monday in Geneva], World Health Organization (WHO) Director-General Margaret Chan said she sees a bright future for health development, despite financial crises that many countries are facing, which has shrunk support for many initiatives,” CIDRAP News reports. According to the news service, “Chan said the WHO can leverage its leadership role to make the most of small and wise investments” and that “[u]niversal health coverage is the best way to maintain health gains that have been made over the past decade” (Schnirring, 5/21). Focusing on innovations that bring social benefit rather than profit, as well as research and development into new treatments, also are important, Chan noted, Devex reports (Ravelo, 5/22).
“Mental illness and drug abuse can wreak havoc in global societies and economies, and the U.N. General Assembly should devote a special session to the matter, global health experts said” in a PLoS Medicine article published on Tuesday, Agence France-Presse reports (1/17). “Mental, neurological, and substance use disorders (MNS) … are leading contributors to the global burden of disease and profoundly impact the social and economic well-being of individuals and communities,” a PLoS press release states, adding, “Yet the majority of people affected by MNS disorders globally do not have access to evidence-based interventions and many experience discrimination and abuses of their human rights” (1/17).